Farshid Fathi

532 total citations
22 papers, 374 citations indexed

About

Farshid Fathi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Farshid Fathi has authored 22 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Farshid Fathi's work include Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 Clinical Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Farshid Fathi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 Clinical Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Farshid Fathi collaborates with scholars based in Iran and United States. Farshid Fathi's co-authors include Nahid Eskandari, Mazdak Ganjalıkhani-Hakemi, Morteza Jafarinia, Hossein Motedayyen, Reza Arefnezhad, Samaneh Mozafarpoor, Ramin Sami, Mahdi Fasihi‐Ramandi, Nasrollah Erfani and Ramezan Ali Taheri and has published in prestigious journals such as PLoS ONE, Cytokine and Current Molecular Medicine.

In The Last Decade

Farshid Fathi

22 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farshid Fathi Iran 12 92 78 51 51 40 22 374
Jinping Wang China 13 94 1.0× 116 1.5× 43 0.8× 35 0.7× 100 2.5× 38 508
Mansur Aliyu Nigeria 7 84 0.9× 94 1.2× 36 0.7× 29 0.6× 48 1.2× 25 328
Ting Zheng China 12 110 1.2× 179 2.3× 78 1.5× 91 1.8× 14 0.3× 29 474
Long Yang China 11 120 1.3× 181 2.3× 41 0.8× 58 1.1× 82 2.0× 31 454
Tanja Džopalić Serbia 10 186 2.0× 82 1.1× 33 0.6× 26 0.5× 21 0.5× 32 404
Marion Brollo France 12 108 1.2× 112 1.4× 29 0.6× 47 0.9× 69 1.7× 23 464
Shiu‐Jau Chen Taiwan 13 36 0.4× 81 1.0× 26 0.5× 30 0.6× 78 1.9× 45 375
Yidan Chen China 13 62 0.7× 145 1.9× 24 0.5× 37 0.7× 83 2.1× 48 554
Fábio Arruda-Silva Italy 9 246 2.7× 93 1.2× 41 0.8× 25 0.5× 29 0.7× 11 388
Kathryn Prame Kumar Australia 8 179 1.9× 179 2.3× 40 0.8× 33 0.6× 62 1.6× 11 517

Countries citing papers authored by Farshid Fathi

Since Specialization
Citations

This map shows the geographic impact of Farshid Fathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshid Fathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshid Fathi more than expected).

Fields of papers citing papers by Farshid Fathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farshid Fathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshid Fathi. The network helps show where Farshid Fathi may publish in the future.

Co-authorship network of co-authors of Farshid Fathi

This figure shows the co-authorship network connecting the top 25 collaborators of Farshid Fathi. A scholar is included among the top collaborators of Farshid Fathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farshid Fathi. Farshid Fathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Khodamoradi, Ehsan, et al.. (2022). Simultaneous effect of gamma and Wi-Fi radiation on gamma-H2Ax expression in peripheral blood of rat: A radio-protection note. Biochemistry and Biophysics Reports. 30. 101232–101232. 2 indexed citations
4.
Aria, Hamid, et al.. (2022). Current advances in stem cell therapy in the treatment of multiple sclerosis. Reviews in the Neurosciences. 34(6). 613–633. 6 indexed citations
5.
Fathi, Farshid, Rezà F. Saidi, Hamid Reza Banafshe, et al.. (2022). Changes in immune profile affect disease progression in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 36. 1190298572–1190298572. 7 indexed citations
6.
7.
Fathi, Farshid, et al.. (2021). Liver Resection Promotes (Regulates) Proinflammatory Cytokines in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 5593655–5593655. 6 indexed citations
8.
Fathi, Farshid, Batool Zamani, Ahmad Piroozmand, et al.. (2021). Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma. Molecular Biology Reports. 48(3). 2047–2052. 11 indexed citations
9.
Karimifar, Mansoor, et al.. (2021). Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index. BMC Research Notes. 14(1). 455–455. 5 indexed citations
10.
Jafarinia, Morteza, et al.. (2020). Quercetin with the potential effect on allergic diseases. Allergy Asthma and Clinical Immunology. 16(1). 36–36. 123 indexed citations
11.
Moloudi, Kave, Hadi Samadian, Mehdi Jaymand, et al.. (2020). Iron oxide/gold nanoparticles‐decorated reduced graphene oxide nanohybrid as the thermo‐radiotherapy agent. IET Nanobiotechnology. 14(5). 428–432. 18 indexed citations
12.
Fathi, Farshid, Ramin Sami, Samaneh Mozafarpoor, et al.. (2020). Immune system changes during COVID-19 recovery play key role in determining disease severity. International Journal of Immunopathology and Pharmacology. 34. 1682203745–1682203745. 33 indexed citations
13.
Fathi, Farshid, et al.. (2019). Association of programmed death‐1 gene polymorphisms with the risk of basal cell carcinoma. International Journal of Immunogenetics. 46(6). 444–450. 15 indexed citations
14.
Rezaei, Nahid, Vahid Shaygannejad, Leila Karimi, et al.. (2019). MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 35. 241–245. 13 indexed citations
15.
Fathi, Farshid, et al.. (2019). Toll-like receptor 4 activation on human amniotic epithelial cells is a risk factor for pregnancy loss. Journal of Research in Medical Sciences. 24(1). 1–1. 18 indexed citations
16.
Fathi, Farshid, et al.. (2019). Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients. Current Molecular Medicine. 19(5). 357–363. 17 indexed citations
17.
Fathi, Farshid, et al.. (2018). The effect of lipopolysaccharide on anti-inflammatory and pro-inflammatory cytokines production of human amniotic epithelial cells. Reproductive Biology. 18(4). 404–409. 14 indexed citations
18.
Fathi, Farshid, et al.. (2018). PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck. Immunological Investigations. 48(1). 1–10. 11 indexed citations
19.
Fathi, Farshid. (2017). Metals in Multiple Sclerosis: Improvement or Progression. 2(2). 1 indexed citations
20.
Firouzabadi, Negar, et al.. (2016). Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. PLoS ONE. 11(4). e0153667–e0153667. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinping Wang Breakdown of academic impact, for papers by Mansur Aliyu Breakdown of academic impact, for papers by Ting Zheng Breakdown of academic impact, for papers by Long Yang Breakdown of academic impact, for papers by Tanja Džopalić Breakdown of academic impact, for papers by Marion Brollo Breakdown of academic impact, for papers by Shiu‐Jau Chen Breakdown of academic impact, for papers by Yidan Chen Breakdown of academic impact, for papers by Fábio Arruda-Silva Breakdown of academic impact, for papers by Kathryn Prame Kumar
Rankless by CCL
2026